Exploratory research to evaluate efficacy and predict prognosis of radiation therapy for malignant glioma using tumor uptake of F-BPA.

Exploratory research to evaluate efficacy and predict prognosis of radiation therapy for malignant glioma using tumor uptake of F-BPA. - Exploratory research to evaluate efficacy and predict prognosis of radiation therapy for malignant glioma using tumor uptake of F-BPA.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000050769

Enrollment

Registered

2023-05-24

Start date

2023-05-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignant glioma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1)Patient with malignant glioma undergoing treatment at Osaka Medical and Pharmaceutical University Hospital. (2)Age at the time of enrollment: 20 years or older. (3)Consent for participation in the study has been obtained.

Exclusion criteria

Exclusion criteria: (1)Pregnant women or those who wish to become pregnant. (2)Under 20years of age. (3)Difficult to evaluate the lesion. (4)Patient who are determined to be unable to safely perform this study.

Design outcomes

Primary

Measure	Time frame
Changes in F-BPA index(SUV= standardized uptake value) before radiotherapy and 3 month after radiotherapy.	—

Countries

Japan

Contacts

Public ContactKeiji Nihei

Osaka Medical and Pharmaceutical University department of radiation oncology

keiji.nihei@ompu.ac.jp072-683-1221

Outcome results